We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » TM Fentanyl Class-Wide REMS Rolls Out in March, FDA Says
TM Fentanyl Class-Wide REMS Rolls Out in March, FDA Says
December 30, 2011
The FDA will begin in March to enforce a new class-wide risk evaluation and mitigation strategy (REMS) for transmucosal immediate-release fentanyl (TIRF) medicines, the first class-wide program for opioids.